TransMedics Group, Inc. (TMDX) stock
TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3029% below fair value
$91.38−0.62 (-0.67%)
Close on Nov 13, 2026Market cap $3.17BP/E 25.0Yield 0.00%
TransMedics gross margin
Gross margin is gross profit as a percentage of revenue.
TransMedics's gross margin for the twelve months ending Sep 30, 2026 was 58.6%. For fiscal 2025 it was 59.9%, against 59.4% the year before. The highest annual figure on record is 69.9% in fiscal 2021.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 59.9% | +0.6 |
| FY2024 | Dec 31, 2024 | 59.4% | −4.4 |
| FY2023 | Dec 31, 2023 | 63.8% | −6.1 |
| FY2022 | Dec 31, 2022 | 69.8% | −0.1 |
| FY2021 | Dec 31, 2021 | 69.9% | +5.0 |
| FY2020 | Dec 31, 2020 | 64.9% | +6.2 |
| FY2019 | Dec 28, 2019 | 58.7% | +14.7 |
| FY2018 | Dec 29, 2018 | 44.1% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 58.5% | −0.4 |
| Q2 FY2026 | Jun 30, 2026 | 59.6% | −1.8 |
| Q1 FY2026 | Mar 31, 2026 | 58.2% | −3.3 |
| Q4 FY2025 | Dec 31, 2025 | 58.1% | −1.1 |
| Q3 FY2025 | Sep 30, 2025 | 58.8% | +2.9 |
| Q2 FY2025 | Jun 30, 2025 | 61.4% | +0.8 |
| Q1 FY2025 | Mar 31, 2025 | 61.5% | −0.4 |
| Q4 FY2024 | Dec 31, 2024 | 59.2% | +0.2 |
| Q3 FY2024 | Sep 30, 2024 | 55.9% | −5.3 |
| Q2 FY2024 | Jun 30, 2024 | 60.6% | −9.4 |
| Q1 FY2024 | Mar 31, 2024 | 61.9% | −7.3 |
| Q4 FY2023 | Dec 31, 2023 | 59.0% | −6.9 |
| Q3 FY2023 | Sep 30, 2023 | 61.2% | −9.3 |
| Q2 FY2023 | Jun 30, 2023 | 70.0% | +0.1 |
| Q1 FY2023 | Mar 31, 2023 | 69.2% | −7.0 |
| Q4 FY2022 | Dec 31, 2022 | 66.0% | −6.3 |
| Q3 FY2022 | Sep 30, 2022 | 70.5% | +0.3 |
| Q2 FY2022 | Jun 30, 2022 | 69.9% | +1.5 |
| Q1 FY2022 | Mar 31, 2022 | 76.2% | +8.0 |
| Q4 FY2021 | Dec 31, 2021 | 72.3% | +9.0 |
| Q3 FY2021 | Sep 30, 2021 | 70.3% | −0.8 |
| Q2 FY2021 | Jun 30, 2021 | 68.4% | +12.1 |
| Q1 FY2021 | Mar 31, 2021 | 68.2% | +3.7 |
| Q4 FY2020 | Dec 31, 2020 | 63.3% | +1.5 |
| Q3 FY2020 | Sep 30, 2020 | 71.0% | +12.5 |
| Q2 FY2020 | Jun 30, 2020 | 56.3% | −2.5 |
| Q1 FY2020 | Mar 31, 2020 | 64.5% | +9.5 |
| Q4 FY2019 | Dec 28, 2019 | 61.8% | +19.5 |
| Q3 FY2019 | Sep 28, 2019 | 58.5% | +5.7 |
| Q2 FY2019 | Jun 29, 2019 | 58.8% | +18.4 |
| Q1 FY2019 | Mar 30, 2019 | 55.0% | +18.3 |
| Q4 FY2018 | Dec 29, 2018 | 42.3% | – |
| Q3 FY2018 | Sep 29, 2018 | 52.8% | – |
| Q2 FY2018 | Jun 30, 2018 | 40.4% | – |
| Q1 FY2018 | Mar 31, 2018 | 36.7% | – |
See a number that looks wrong?